Vildagliptin (LAF-237) - Moligand™, 10mM in DMSO , Dipeptidyl peptidase IV inhibitor, CAS No.274901-16-5, Dipeptidyl peptidase IV inhibitor

CAS: 274901-16-5 Cat. No.: V408745 분자식: C17H25N3O2 분자량: 303.4 EC 번호: 630-410-0 PubChem CID: 6918537
주문 가능
등급 & 순도 Moligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools. 10mM in DMSO
Synonyms
2-Pyrrolidinecarbonitrile, 1-[2-[(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]-, (2S)-
Storage
Store at -80°C
Shipped In
Dry ice packs + Cold packs
★
크기
USA
독일 (EU)*
가격
수량
1ml
V408745-1ml
2 재고 있음
—

US$181.90

US$265.90
저장 US$84.00 (31.59%)
Enter a quantity for the sizes you want to add.

개요

Information

Vildagliptin (LAF-237) Vildagliptin (LAF-237) inhibits DPP−4 with IC50 of 2.3 nM.
In vitro

Vildagliptin is the most stable DPP-IV inhibitor, binding in the S1- and S2-catalytic sites of DPP-IV, possessing a P-1 site transition-state mimetic.

In vivo

Vildagliptin(orally dosed with 10 μmol/kg) is a potent, orally active inhibitor of plasma DPP-IV activity that provides increased levels of GLP-1 in an oral glucose tolerance test (OGTT) with Obese male Zucker rats. Vildagliptin orally dosed with 10 μmol/kg both significantly decreases glucose excursions and stimulates insulin secretion in Obese male Zucker rats. Maximum inhibition of plasma DPP-IV activity (95%) is observed approximately 2 hours postdose of Vildagliptin (1 μmol/kg, po) while >50% inhibition of DPP-IV is observed within 30 min postdose and persisted for >10 hours in normal Cynomolgus monkeys. Vildagliptin(60 mg/kg) increases pancreatic beta cell mass through enhanced beta cell replication and reduced apoptosis, and the increased beta cell mass is sustained for 12 days after vildagliptin washout. Vildagliptin administrated at doses of 10 mg/kg for 32 weeks protects nerve fiber loss in streptozotocin (STZ)-induced diabetic adult male Sprague Dawley rats.
Cell Data

cell lines:MCF7, NCI-H292, Colo-205, HT29, H358, H1703, BxPC3, A673, SW620, DU4475, HepG2 and Hepa-1, RKO 3T3/hulGF-IR and H292 cells

Concentrations:

Incubation Time:

Powder Purity:≥99%

사양

동의어
2-Pyrrolidinecarbonitrile, 1-[2-[(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]-, (2S)-
사양 및 순도
Moligand™, 10mM in DMSO
생화학 및 생리적 메커니즘
Vildagliptin (LAF-237) inhibits DPP−4 with IC50 of 2.3 nM.
보관 조건
Store at -80°C
배송
Dry ice packs + Cold packs
이 제품은 콜드 체인 배송이 필요합니다.지상 및 기타 경제 서비스는 사용할 수 없습니다.
등급
Moligand™
작업 유형
ACTIVATOR, INHIBITOR
작동 메커니즘
Dipeptidyl peptidase IV inhibitor
제품 특성
ALogP
0.9
이름과 식별자
이성체 SMILES
C1C[C@H](N(C1)C(=O)CNC23CC4CC(C2)CC(C4)(C3)O)C#N
PubChem CID
6918537
분자량
303.4

고급 데이터

관련 대상(인간)
DPP4 Tclin Dipeptidyl peptidase 4 (36 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
DPP8 Tchem Dipeptidyl peptidase 8 (2 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
DPP9 Tchem Dipeptidyl peptidase 9 (12 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
인증서(CoA, COO, BSE/TSE 및 분석 차트)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

1 results found

Lot NumberCertificate Type날짜항목
C2310997C2310997Certificate of AnalysisOct 12, 2026 V408745
화학 및 물리적 특성
용해성Solubility (25°C) In vitro DMSO: 50 mg/mL (61.6 mM);    
안전 및 위험(GHS)
위험 문구

H413:May cause long lasting harmful effects to aquatic life

주의 문구

P273:Avoid release to the environment.

P501:Dispose of contents/container to an approved waste disposal plant.

자주 묻는 질문과 기사
Citations of This Product
솔루션 계산기
리뷰

고객 리뷰

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.